Intervention

NPH insulin

ClinicalTrials.gov intervention label

Clinical trials14

Recruiting0

Common conditions13

Lead sponsors shown8

Clinical trials

14 shown

Intermediate and Long Acting Insulin Young Children Type 1 Diabetes.NCT04664764 · 2019-02-21

Insulin Schemes for Type 2 Diabetes ControlNCT03350984 · 2017-11-02

A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes MellitusNCT02910518 · 2017-02-17

A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Insulin in Patients Already Using Basal InsulinNCT02967211 · 2015-12-21

A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Insulins in Insulin Naïve Patients Initiating InsulinNCT02967224 · 2015-11-05

Glargine Versus NPH in Patients With Chronic Kidney DiseaseNCT02451917 · 2013-12-01

Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.NCT01223131 · 2011-02-01

Sitagliptin (DPP-4 Inhibitor) and NPH Insulin in Patients With T2DNCT02607410 · 2010-01-01

Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH) Insulin in Pregnant Women With Type 1 DiabetesNCT00474045 · 2007-05-01

Glycemic And Blood Pressure Control In Type 2 Diabetes, In A Primary Care Unit: A Staged Management StrategyNCT00935805 · 2006-07-01

Basal Analog Study - Comparison of Lantus or Levemir With NPH Insulin From T1DM DiagnosisNCT01271517 · 2005-09-01

Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and AdolescentsNCT00115570 · 2005-04-01

Comparison of Insulin Glargine and NPH Insulin at Night and at Hypoglycemia in Type 2 DiabetesNCT00468364 · 2003-07-01

Evaluation of the Efficacy and Safety of Insulin Detemir Compared With That of NPH Insulin in Subjects With Type 1 Diabetes.NCT03220425 · 2001-02-01

Common conditions

Type 2 Diabetes Mellitus3 Diabetes2 Diabetes Mellitus, Type 12 Diabetes Mellitus, Type 22 Arterial Hypertension1 Chronic Kidney Disease1 Diabetes Mellitus1 Diabetes Mellitus Type 11 Diabetes Mellitus, Insulin-Dependent1 Type 1 Diabetes Mellitus1 Type 1 Diabetes Mellitus With Hypoglycemia1 Type1 Diabetes Mellitus1 type1diabetes1

Leading sponsors

Sanofi5 Novo Nordisk A/S2 University of Sao Paulo General Hospital2 Ain Shams University1 Hospital de Clinicas de Porto Alegre1 Karolinska Institutet1 Universidad de Guanajuato1 University of Giessen1

Trial status mix

COMPLETED11

UNKNOWN3

Phase mix

PHASE47

PHASE34

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.